MSIpad - Mass Spectrometry Imaging for pathology and drug discovery
From 01-01-2015 to 31-12-2016
Description
In this project we will explore the application of Mass Spectrometry-based Imaging (MSI) of tissues as a universal toolbox in clinical pathology and drug discovery. This tool can provide an objective and evidence-based interpretation in cases where classical tools do not allow proper differentiation, e.g. in order to reach optimal clinical management and patient outcome.
The major drawbacks of MSI are the high costs, the long measuring time and the complex dataprocessing. These drawbacks will be tackled in this project and the applied strategy will be evaluated using 2 selected case studies. Also the applicability in the larger community will be evaluated. The consortium represents all relevant stakeholders, covering hardware, software, end-users (pathology and biotech), reference leaders in clinical pathology and business modeling.
Team
- Bart De Moor, Co-promoter
- Etienne Waelkens, Co-promoter (External)
- Thomas Tousseyn, External Partner (External)
- Gerard Griffioen, External Partner (External)
- Wim Waelput, Project Leader (External)
- Nico Verbeeck, Proposal Manager
- Dusan Popovic, Research Leader
Financing
Funding: iMinds - Flanders' digital research center and incubator
Program/Grant Type: ICON - iMinds ICON
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.